ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peramivir Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-8X8655
Home | Market Reports | Health| Pharmacy
Global Peramivir Market Insights Forecast to 2028
BUY CHAPTERS

Global Peramivir Market Research Report 2025

Code: QYRE-Auto-8X8655
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi
Neopharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma

Peramivir Market

The global market for Peramivir was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Peramivir is a synthetic cyclopentane derivative. The groups connected to the ring include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four groups with different polarities act on Different active site regions in the NA structure of influenza virus. This medicine is suitable for treating influenza A and is mainly administered intravenously in the form of sodium chloride solution.
North American market for Peramivir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peramivir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peramivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peramivir.
The Peramivir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peramivir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peramivir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peramivir Market Report

Report Metric Details
Report Name Peramivir Market
Segment by Type
  • Solution
  • Solid
Segment by Application
  • Influenza A Treatment
  • Influenza B Treatment
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peramivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Peramivir Market report?

Ans: The main players in the Peramivir Market are BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma

What are the Application segmentation covered in the Peramivir Market report?

Ans: The Applications covered in the Peramivir Market report are Influenza A Treatment, Influenza B Treatment

What are the Type segmentation covered in the Peramivir Market report?

Ans: The Types covered in the Peramivir Market report are Solution, Solid

1 Peramivir Market Overview
1.1 Product Definition
1.2 Peramivir by Type
1.2.1 Global Peramivir Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solution
1.2.3 Solid
1.3 Peramivir by Application
1.3.1 Global Peramivir Market Value by Application (2024 VS 2031)
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size Estimates and Forecasts
1.4.1 Global Peramivir Revenue 2020-2031
1.4.2 Global Peramivir Sales 2020-2031
1.4.3 Global Peramivir Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peramivir Market Competition by Manufacturers
2.1 Global Peramivir Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peramivir Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peramivir Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peramivir, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peramivir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peramivir, Product Type & Application
2.7 Global Key Manufacturers of Peramivir, Date of Enter into This Industry
2.8 Global Peramivir Market Competitive Situation and Trends
2.8.1 Global Peramivir Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peramivir Players Market Share by Revenue
2.8.3 Global Peramivir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peramivir Market Scenario by Region
3.1 Global Peramivir Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peramivir Sales by Region: 2020-2031
3.2.1 Global Peramivir Sales by Region: 2020-2025
3.2.2 Global Peramivir Sales by Region: 2026-2031
3.3 Global Peramivir Revenue by Region: 2020-2031
3.3.1 Global Peramivir Revenue by Region: 2020-2025
3.3.2 Global Peramivir Revenue by Region: 2026-2031
3.4 North America Peramivir Market Facts & Figures by Country
3.4.1 North America Peramivir Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peramivir Sales by Country (2020-2031)
3.4.3 North America Peramivir Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peramivir Market Facts & Figures by Country
3.5.1 Europe Peramivir Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peramivir Sales by Country (2020-2031)
3.5.3 Europe Peramivir Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peramivir Market Facts & Figures by Region
3.6.1 Asia Pacific Peramivir Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peramivir Sales by Region (2020-2031)
3.6.3 Asia Pacific Peramivir Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peramivir Market Facts & Figures by Country
3.7.1 Latin America Peramivir Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peramivir Sales by Country (2020-2031)
3.7.3 Latin America Peramivir Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peramivir Market Facts & Figures by Country
3.8.1 Middle East and Africa Peramivir Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peramivir Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peramivir Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peramivir Sales by Type (2020-2031)
4.1.1 Global Peramivir Sales by Type (2020-2025)
4.1.2 Global Peramivir Sales by Type (2026-2031)
4.1.3 Global Peramivir Sales Market Share by Type (2020-2031)
4.2 Global Peramivir Revenue by Type (2020-2031)
4.2.1 Global Peramivir Revenue by Type (2020-2025)
4.2.2 Global Peramivir Revenue by Type (2026-2031)
4.2.3 Global Peramivir Revenue Market Share by Type (2020-2031)
4.3 Global Peramivir Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peramivir Sales by Application (2020-2031)
5.1.1 Global Peramivir Sales by Application (2020-2025)
5.1.2 Global Peramivir Sales by Application (2026-2031)
5.1.3 Global Peramivir Sales Market Share by Application (2020-2031)
5.2 Global Peramivir Revenue by Application (2020-2031)
5.2.1 Global Peramivir Revenue by Application (2020-2025)
5.2.2 Global Peramivir Revenue by Application (2026-2031)
5.2.3 Global Peramivir Revenue Market Share by Application (2020-2031)
5.3 Global Peramivir Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BioCryst Pharmaceuticals
6.1.1 BioCryst Pharmaceuticals Company Information
6.1.2 BioCryst Pharmaceuticals Description and Business Overview
6.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BioCryst Pharmaceuticals Peramivir Product Portfolio
6.1.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.2 Green Cross Pharma
6.2.1 Green Cross Pharma Company Information
6.2.2 Green Cross Pharma Description and Business Overview
6.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Green Cross Pharma Peramivir Product Portfolio
6.2.5 Green Cross Pharma Recent Developments/Updates
6.3 Shionogi Co.
6.3.1 Shionogi Co. Company Information
6.3.2 Shionogi Co. Description and Business Overview
6.3.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shionogi Co. Peramivir Product Portfolio
6.3.5 Shionogi Co. Recent Developments/Updates
6.4 NeoPharm
6.4.1 NeoPharm Company Information
6.4.2 NeoPharm Description and Business Overview
6.4.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NeoPharm Peramivir Product Portfolio
6.4.5 NeoPharm Recent Developments/Updates
6.5 Moksha8 Pharma
6.5.1 Moksha8 Pharma Company Information
6.5.2 Moksha8 Pharma Description and Business Overview
6.5.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Moksha8 Pharma Peramivir Product Portfolio
6.5.5 Moksha8 Pharma Recent Developments/Updates
6.6 NT Pharma
6.6.1 NT Pharma Company Information
6.6.2 NT Pharma Description and Business Overview
6.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NT Pharma Peramivir Product Portfolio
6.6.5 NT Pharma Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Peramivir Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Company Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Pharmaceuticals Peramivir Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Hunan Nucien Pharmaceutical Co., Ltd.
6.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Company Information
6.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
6.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 SCOLR Pharma
6.10.1 SCOLR Pharma Company Information
6.10.2 SCOLR Pharma Description and Business Overview
6.10.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SCOLR Pharma Peramivir Product Portfolio
6.10.5 SCOLR Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peramivir Industry Chain Analysis
7.2 Peramivir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peramivir Production Mode & Process Analysis
7.4 Peramivir Sales and Marketing
7.4.1 Peramivir Sales Channels
7.4.2 Peramivir Distributors
7.5 Peramivir Customer Analysis
8 Peramivir Market Dynamics
8.1 Peramivir Industry Trends
8.2 Peramivir Market Drivers
8.3 Peramivir Market Challenges
8.4 Peramivir Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi
Neopharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
List of Tables
 Table 1. Global Peramivir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peramivir Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peramivir Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peramivir Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Peramivir Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peramivir Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peramivir Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peramivir Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peramivir, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peramivir, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peramivir, Product Type & Application
 Table 12. Global Key Manufacturers of Peramivir, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peramivir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peramivir as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peramivir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peramivir Sales by Region (2020-2025) & (Tons)
 Table 18. Global Peramivir Sales Market Share by Region (2020-2025)
 Table 19. Global Peramivir Sales by Region (2026-2031) & (Tons)
 Table 20. Global Peramivir Sales Market Share by Region (2026-2031)
 Table 21. Global Peramivir Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peramivir Revenue Market Share by Region (2020-2025)
 Table 23. Global Peramivir Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peramivir Revenue Market Share by Region (2026-2031)
 Table 25. North America Peramivir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peramivir Sales by Country (2020-2025) & (Tons)
 Table 27. North America Peramivir Sales by Country (2026-2031) & (Tons)
 Table 28. North America Peramivir Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peramivir Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peramivir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peramivir Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Peramivir Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Peramivir Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peramivir Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peramivir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peramivir Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Peramivir Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Peramivir Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peramivir Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peramivir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peramivir Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Peramivir Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Peramivir Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peramivir Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peramivir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peramivir Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Peramivir Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Peramivir Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peramivir Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peramivir Sales (Tons) by Type (2020-2025)
 Table 51. Global Peramivir Sales (Tons) by Type (2026-2031)
 Table 52. Global Peramivir Sales Market Share by Type (2020-2025)
 Table 53. Global Peramivir Sales Market Share by Type (2026-2031)
 Table 54. Global Peramivir Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peramivir Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peramivir Revenue Market Share by Type (2020-2025)
 Table 57. Global Peramivir Revenue Market Share by Type (2026-2031)
 Table 58. Global Peramivir Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Peramivir Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Peramivir Sales (Tons) by Application (2020-2025)
 Table 61. Global Peramivir Sales (Tons) by Application (2026-2031)
 Table 62. Global Peramivir Sales Market Share by Application (2020-2025)
 Table 63. Global Peramivir Sales Market Share by Application (2026-2031)
 Table 64. Global Peramivir Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peramivir Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peramivir Revenue Market Share by Application (2020-2025)
 Table 67. Global Peramivir Revenue Market Share by Application (2026-2031)
 Table 68. Global Peramivir Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Peramivir Price (US$/Kg) by Application (2026-2031)
 Table 70. BioCryst Pharmaceuticals Company Information
 Table 71. BioCryst Pharmaceuticals Description and Business Overview
 Table 72. BioCryst Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. BioCryst Pharmaceuticals Peramivir Product
 Table 74. BioCryst Pharmaceuticals Recent Developments/Updates
 Table 75. Green Cross Pharma Company Information
 Table 76. Green Cross Pharma Description and Business Overview
 Table 77. Green Cross Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Green Cross Pharma Peramivir Product
 Table 79. Green Cross Pharma Recent Developments/Updates
 Table 80. Shionogi Co. Company Information
 Table 81. Shionogi Co. Description and Business Overview
 Table 82. Shionogi Co. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Shionogi Co. Peramivir Product
 Table 84. Shionogi Co. Recent Developments/Updates
 Table 85. NeoPharm Company Information
 Table 86. NeoPharm Description and Business Overview
 Table 87. NeoPharm Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. NeoPharm Peramivir Product
 Table 89. NeoPharm Recent Developments/Updates
 Table 90. Moksha8 Pharma Company Information
 Table 91. Moksha8 Pharma Description and Business Overview
 Table 92. Moksha8 Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Moksha8 Pharma Peramivir Product
 Table 94. Moksha8 Pharma Recent Developments/Updates
 Table 95. NT Pharma Company Information
 Table 96. NT Pharma Description and Business Overview
 Table 97. NT Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. NT Pharma Peramivir Product
 Table 99. NT Pharma Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Merck Peramivir Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Hikma Pharmaceuticals Company Information
 Table 106. Hikma Pharmaceuticals Description and Business Overview
 Table 107. Hikma Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Hikma Pharmaceuticals Peramivir Product
 Table 109. Hikma Pharmaceuticals Recent Developments/Updates
 Table 110. Hunan Nucien Pharmaceutical Co., Ltd. Company Information
 Table 111. Hunan Nucien Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product
 Table 114. Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. SCOLR Pharma Company Information
 Table 116. SCOLR Pharma Description and Business Overview
 Table 117. SCOLR Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. SCOLR Pharma Peramivir Product
 Table 119. SCOLR Pharma Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Peramivir Distributors List
 Table 123. Peramivir Customers List
 Table 124. Peramivir Market Trends
 Table 125. Peramivir Market Drivers
 Table 126. Peramivir Market Challenges
 Table 127. Peramivir Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peramivir
 Figure 2. Global Peramivir Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peramivir Market Share by Type: 2024 & 2031
 Figure 4. Solution Product Picture
 Figure 5. Solid Product Picture
 Figure 6. Global Peramivir Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peramivir Market Share by Application: 2024 & 2031
 Figure 8. Influenza A Treatment
 Figure 9. Influenza B Treatment
 Figure 10. Global Peramivir Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Peramivir Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Peramivir Sales (2020-2031) & (Tons)
 Figure 13. Global Peramivir Average Price (US$/Kg) & (2020-2031)
 Figure 14. Peramivir Report Years Considered
 Figure 15. Peramivir Sales Share by Manufacturers in 2024
 Figure 16. Global Peramivir Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Peramivir Players: Market Share by Revenue in Peramivir in 2024
 Figure 18. Peramivir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Peramivir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Peramivir Sales Market Share by Country (2020-2031)
 Figure 21. North America Peramivir Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Peramivir Sales Market Share by Country (2020-2031)
 Figure 25. Europe Peramivir Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Peramivir Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Peramivir Revenue Market Share by Region (2020-2031)
 Figure 33. China Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Peramivir Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Peramivir Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Peramivir Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Peramivir Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Peramivir Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Peramivir by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Peramivir by Type (2020-2031)
 Figure 55. Global Peramivir Price (US$/Kg) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Peramivir by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Peramivir by Application (2020-2031)
 Figure 58. Global Peramivir Price (US$/Kg) by Application (2020-2031)
 Figure 59. Peramivir Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Peramivir API Market Research Report 2025
Global Antiviral Drugs for Influenza Market Research Report 2025
Rimantadine Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Zanamivir Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oseltamivir Market Insights Forecast to 2030
Cyclopentylamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tamiflu Oseltamivir Phosphate Market Insights Forecast to 2030
Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030
Global Oseltamivir Phosphate API Market Research Report 2025
Global Influenza Therapeutics Market Insights Forecast to 2030
Global Neuraminidase Inhibitor Market Research Report 2024
Global Abacavir Sulfate API Market Research Report 2024
Influenza Antiviral Drugs Market
Oseltamivir Phosphate Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Telaprevir Market Research Report 2024
Global Medical Cycloolefin Polymers Market Research Report 2024
Perindopril Arginine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Favipiravir Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Valacyclovir Hcl API Market Research Report 2025
Global Minocycline Hydrochloride Tablets Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions